greeksoup/ stock research
Stock research / United States / TECH / Planned sales

Bio-Techne Corp. planned insider sales

In the last twelve months insiders at Bio-Techne Corp. filed 2 Form 144 notices of planned sales, 8,612 shares worth $437,209 at the time of filing, from 1 seller. The latest, filed 8 May 2026: Joshua Molho (director), 6,636 shares worth $320,417, planned for around 8 May 2026 through Morgan Stanley Smith Barney LLC Executive Financial Services.

FiledSellerRelationshipSharesValuePlanned saleSold, per Form 4BrokerHow acquiredFiling
8 May 2026Joshua MolhoDirector6,636$320,4178 May 2026No matching Form 4 saleMorgan Stanley Smith Barney LLC Executive Financial ServicesExercise of options under a registered planForm 144
17 February 2026Joshua MolhoDirector1,976$116,79117 February 2026No matching Form 4 saleMorgan Stanley Smith Barney LLC Executive Financial ServicesPreviously Exercised OptionsForm 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Sold, per Form 4: the same seller's open-market sales on Form 4 from the notice's date to 90 days after, added up, as they appear on the insiders page; a holder who files no Form 4, such as some large holders, never shows one. What is a Form 144?